GlobeNewswire 2022-02-24 Galapagos 2021 results set stage for future growth
GlobeNewswire 2022-02-24 Gritstone to Participate in Cowen 42nd Annual Health Care Conference
GlobeNewswire 2022-02-08 Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 2022-02-08 Rain Therapeutics Continues to Strengthen its Leadership Team with Key Appointments
GlobeNewswire 2022-02-08 Gritstone to Participate in Precision Oncology Panel at BIO CEO & Investor Conference
GlobeNewswire 2022-02-02 Galapagos provides further insights into the treatment of ulcerative colitis at the European Crohn’s...
GlobeNewswire 2022-02-02 Bluejay Therapeutics Announces the Appointment of Nancy Shulman, M.D., as Chief Medical Officer
TeleTrader 2022-02-01 Gilead: Q4 EPS plunge 75% to $0.3
TeleTrader 2022-02-01 Nasdaq 100 turns to losses ahead of earnings
GlobeNewswire 2022-01-25 Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
TeleTrader 2022-01-22 FDA approves remdesivir for some non-hospitalized patients
GlobeNewswire 2022-01-19 Foresight Diagnostics Establishes Scientific Advisory Board with Appointment of Sandra Horning, M.D.
GlobeNewswire 2022-01-19 Recro Appoints Eduardo Uribe as Head of Quality for Recro San Diego
GlobeNewswire 2022-01-18 Fountain Therapeutics Announces Appointment of Anupama Hoey as Chief Business Officer
GlobeNewswire 2022-01-13 Gritstone Announces First Patient Enrolled for Phase 2/3 Trial Evaluating Individualized Neoantigen ...
GlobeNewswire 2022-01-10 Amarin Provides Preliminary 2021 Revenue and Outlook for 2022
GlobeNewswire 2022-01-06 Adverum Biotechnologies Appoints Star Seyedkazemi, Pharm.D. as Chief Development Officer
GlobeNewswire 2022-01-04 Jounce Therapeutics to Present at Upcoming Investor Conferences in January
GlobeNewswire 2022-01-04 Gritstone Announces Positive Clinical Results from First Cohort of a Phase 1 Study (CORAL-BOOST) Eva...
GlobeNewswire 2021-12-30 Gritstone Announces Presentations during Three Upcoming Investor Conferences
GlobeNewswire 2021-12-27 Pardes Biosciences Debuts as a Publicly Traded Company Focused on Oral Antiviral Therapies to Potent...
GlobeNewswire 2021-12-21 HPTN Studies Inform FDA’s Approval of ViiV Healthcare’s Long-Acting Cabotegravir Injections for HIV ...
GlobeNewswire 2021-12-17 Sigyn Therapeutics CEO Note: As Omicron Surges, Consider That the First Authorized COVID-19 Therapie...
GlobeNewswire 2021-12-17 Gritstone Announces Changes to Its Board of Directors
GlobeNewswire 2021-12-16 Bolt Biotherapeutics Appoints Nicole Onetto, M.D., to Board of Directors